A Comparison of the Therapeutic Efficacy of Cefuroxime versus 1 Cefotaxime as an Initial Antimicrobial Therapy for Community-2 Onset Complicated Non-Obstructive Acute Pyelonephritis due to 3 Enterobacteriaceae Infection in Women Using Propensity-4 Matched Analysis 5 6
暂无分享,去创建一个
[1] K. Kwon,et al. Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] K. Ko,et al. Predictors of uropathogens other than Escherichia coli in patients with community‐onset acute pyelonephritis , 2014, International journal of clinical practice.
[3] S. Wie,et al. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience. , 2013, Microbial drug resistance.
[4] W. Lee,et al. Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis , 2011, Yonsei medical journal.
[5] K. Naber,et al. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. , 2011, International journal of antimicrobial agents.
[6] L. Nicolle. Update in Adult Urinary Tract Infection , 2011, Current infectious disease reports.
[7] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Bader,et al. Management of Complicated Urinary Tract Infections in the Era of Antimicrobial Resistance , 2010, Postgraduate medicine.
[9] Manabu Igarashi,et al. Efficacy of treatment with carbapenems and third-generation cephalosporins for patients with febrile complicated pyelonephritis , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[10] S. Geerlings,et al. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] D. Haverstock,et al. Risk factors for a poor outcome after therapy for acute pyelonephritis , 2006, BJU international.
[12] K. Ramakrishnan,et al. Diagnosis and management of acute pyelonephritis in adults. , 2005, American family physician.
[13] T. Mountokalakis,et al. Acute pyelonephritis in adults: prediction of mortality and failure of treatment. , 2003, Archives of internal medicine.
[14] G. Harding,et al. Complicated urinary tract infections. , 1997, Infectious disease clinics of North America.
[15] Ronald N. Jones,et al. Cefuroxime, a New Parenteral Cephalosporin: Collaborative In Vitro Susceptibility Comparison with Cephalothin Against 5,887 Clinical Bacterial Isolates , 1977, Antimicrobial Agents and Chemotherapy.
[16] C. O'callaghan,et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro , 1976, Antimicrobial Agents and Chemotherapy.